CASI Pharmaceuticals annual net debt
2021
2022
2023
2024
2025
CASI Pharmaceuticals Net Debt Growth & History (CASIF)
CASI Pharmaceuticals's net debt was $16.6M for fiscal 2025.
View full CASI Pharmaceuticals company overviewCASI Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.6M | $7.9M | +91.51% |
| 2024 | 2024-12-31 | $8.7M | $4.5M | +108.69% |
| 2023 | 2023-12-31 | $4.2M | $49.9M | — |
| 2022 | 2022-12-31 | −$45.8M | −$9.2M | — |
| 2021 | 2021-12-31 | −$36.5M | — | — |
CASI Pharmaceuticals quarterly net debt
Q4.21
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $36.7M | $24.7M | +206.25% |
| Q4 2025 | 2025-12-31 | $16.6M | $7.9M | +91.51% |
| Q3 2025 | 2025-09-30 | $14.2M | — | — |
| Q2 2025 | 2025-06-30 | $12.0M | — | — |
| Q1 2025 | 2025-03-31 | $7.6M | — | — |
| Q4 2024 | 2024-12-31 | $8.7M | $4.5M | +108.69% |
| Q4 2023 | 2023-12-31 | $4.2M | $49.9M | — |
| Q4 2022 | 2022-12-31 | −$45.8M | −$9.2M | — |
| Q4 2021 | 2021-12-31 | −$36.5M | — | — |
CASI Pharmaceuticals net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, CASI Pharmaceuticals's net debt increased from −$36.5M to $16.6M, a change of $53.1M. The latest reported quarter, Q2 2026, shows $36.7M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CASI Pharmaceuticals source filings ↗